Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 20Rectal Neoplasms 11Carcinoma, Hepatocellular 7Neoplasm Metastasis 5Stomach Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Liver Neoplasms 2Recurrence 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Neoplasm, Residual 1Neoplasm Recurrence, Local 1Margins of Excision 1Locally Advanced Rectal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

Dexamethasone 28Rituximab 16pomalidomide 13Gemcitabine 12Lenalidomide 11Cisplatin 11Bortezomib 11Paclitaxel 10Cyclophosphamide 8Carboplatin 8carfilzomib 7selinexor 5daratumumab 5Drug Therapy 5Doxorubicin 5Cytarabine 5ibrutinib 4Vincristine 4Temozolomide 4Prednisone 4Docetaxel 4Calcium Dobesilate 4Bevacizumab 4Aspirin 4tisagenlecleucel 3Cetuximab 3Bendamustine Hydrochloride 3venetoclax 2ofatumumab 2galiximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Recurrence × Folfox protocol × Clear all
NCT02738697 2016-11-02

Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection

Sun Yat-sen University

Phase 3 Unknown
290 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡